Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
Sponsor: Mirati Therapeutics Inc.
Check if you qualify for this non-small cell lung cancer clinical trial in Birmingham, AL
If you're searching for non-small cell lung cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.